By Jan Wolfe
(Reuters) – Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to deve… [+1880 chars]
Moderna loses challenge to Arbutus patent on vaccine technology – Yahoo Finance
